Share
Significant health care cases of 2022 included a surprise billing unfair trade practices case, a class action recognizing a patient’s constitutionally protected interest in their inpatient classification and a ruling recognizing “innovator liability” of a brand name drug’s developer for the harm to a consumer by a bio-equivalent genetic drug. Various courts also addressed informed consent standards, the duty of medical device manufacturers to warn of safety risks and, lastly, the meaning of “actionable harm” in the context of medical malpractice actions. More about these and some additional cases follows.
The purpose of this Alert is to summarize key cases decided during the past year; please refer to the cases for complete information.
Read on for other significant case law (click here to view) that may affect your organization or practice and for more information, please contact one of our Health Care Law attorneys.
Related Practices & Industries
This blog/web site presents general information only. The information you obtain at this site is not, nor is it intended to be, legal advice, and you should not consider or rely on it as such. You should consult an attorney for individual advice regarding your own situation. This website is not an offer to represent you. You should not act, or refrain from acting, based upon any information at this website. Neither our presentation of such information nor your receipt of it creates nor will create an attorney-client relationship with any reader of this blog. Any links from another site to the blog are beyond the control of Pullman & Comley, LLC and do not convey their approval, support or any relationship to any site or organization. Any description of a result obtained for a client in the past is not intended to be, and is not, a guarantee or promise the firm can or will achieve a similar outcome.
About Our Connecticut Health Law Blog
Alerts, commentary and insights from the attorneys of Pullman & Comley’s Health Care practice on legal developments affecting hospitals, physician groups, pharmaceutical and medical device companies as well as other health care providers and suppliers.